3. How are biosimilars approved in Europe and who decides on the availability?

This patient toolkit has been developed by ecancer in collaboration with the European Cancer Patient Coalition to provide patients with a comprehensive resource on biosimilar medicines. Six modules provide key information and practical advice to support you in making informed decisions for your treatment.

This e-learning resource is supported through an unrestricted education grant from Pfizer.

Related resources

Card image cap
SERIES
>

Biosimilar Medicines

A series of videos about Biosimilars explaining their use in cancer treatment.

watch
Card image cap

Coronavirus (COVID-19) and Cancer: A Guide for Patients

This patient resource was created as an informative reassurance for cancer patients and their carers around the world during the Coronavirus (COVID-19) pandemic, and aims to clarify most of the questions you have about cancer treatment during this time.

watch
Loading...